Evolus, Inc.
Develops neurotoxins and dermal fillers for the medical aesthetics market.
EOLS | NDAQ
Overview
Corporate Details
- ISIN(s):
- US30052C1071
- LEI:
- Country:
- United States of America
- Address:
- 520 NEWPORT CENTER DRIVE, 92660 NEWPORT BEACH
- Website:
- https://www.evolus.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Evolus, Inc. is a performance beauty company that develops and commercializes products for the medical aesthetics market. The company operates within the cash-pay aesthetic sector, providing treatments to consumers through licensed healthcare practitioners. Its flagship product is Jeuveau® (prabotulinumtoxinA-xvfs), a neurotoxin used for the temporary improvement of moderate to severe glabellar lines. The company is also expanding its portfolio with the Evolysse™ line of dermal fillers. Evolus focuses on a customer-centric approach to deliver breakthrough products for the aesthetics market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Evolus, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evolus, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evolus, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
